Besides directly inhibiting the activity of mushroom tyrosinase, dieckol also reduced the melanin content in α-melanocyte stimulating hormone (α-MSH)-elicited B16F10 melanoma cells, by the inhibition of murine tyrosinase, more effectively than the commercial agent arbutin [56]. The gene discussed is TYR; the disease is melanoma.